arrow
Back
H

Hiroshi Fukui

Nara Medical University

56H-index
470Paper Count
1.9WCitation Count
Published Papers 114
Publication Date
von Willebrand factor is a useful biomarker for liver fibrosis and prediction of hepatocellular carcinoma development in patients with hepatitis B and C
err2018-11-01
err38
errOAAI
errTakaya, Hiroaki; Kawaratani, Hideto; Tsuji, Yuki; Nakanishi, Keisuke; Saikawa, Soichiro; Sato, Shinya; Sawada, Yasuhiko; Kaji, Kosuke; Okura, Yasushi; Shimozato, Naotaka; Kitade, Mitsuteru; Akahane, Takemi; Moriya, Kei; Namisaki, Tadashi; Mitoro, Akira; Matsumoto, Masanori; Fukui, Hiroshi; Yoshiji, Hitoshi
errShare
errSave
Comprehensive analysis of ADAMTS13 in patients with liver cirrhosis
err2017-11-27
err121
PREAI
errUemura, Masahito; Fujimura, Yoshihiro; Matsumoto, Masanori; Ishizashi, Hiromichi; Kato, Seiji; Matsuyama, Tomomi; Isonishi, Ayami; Ishikawa, Masatoshi; Yagita, Masato; Morioka, Chie; Yoshiji, Hitoshi; Tsujimoto, Tatsuhiro; Kurumatani, Norio; Fukui, Hiroshi
errShare
errSave
Platelet hyperaggregability is associated with decreased ADAMTS13 activity and enhanced endotoxemia in patients with acute cholangitis
err2017-07-20
err13
errOAAI
errTakaya, Hiroaki; Kawaratani, Hideto; Kubo, Takuya; Seki, Kenichiro; Sawada, Yasuhiko; Kaji, Kosuke; Okura, Yasushi; Takeda, Kosuke; Kitade, Mitsuteru; Moriya, Kei; Namisaki, Tadashi; Mitoro, Akira; Matsumoto, Masanori; Fukui, Hiroshi; Yoshiji, Hitoshi
errShare
errSave
Predictive parameter of tolvaptan effectiveness in cirrhotic ascites
err2016-11-09
err28
PREAI
errKawaratani, Hideto; Fukui, Hiroshi; Moriya, Kei; Noguchi, Ryuichi; Namisaki, Tadashi; Uejima, Masakazu; Kitade, Mitsuteru; Takeda, Kosuke; Okura, Yasushi; Kaji, Kosuke; Nishimura, Norihisa; Takaya, Hiroaki; Aihara, Yousuke; Sawada, Yasuhiko; Sato, Shinya; Seki, Kenichiro; Mitoro, Akira; Yamao, Junichi; Yoshiji, Hitoshi
errShare
errSave
Treatment for cirrhotic ascites
err2016-07-27
err25
PREAI
errKawaratani, Hideto; Fukui, Hiroshi; Yoshiji, Hitoshi
errShare
errSave
Evidence-based clinical practice guidelines for liver cirrhosis 2015
err2016-05-31
err267
errOAAI
errFukui, Hiroshi; Saito, Hidetsugu; Ueno, Yoshiyuki; Uto, Hirofumi; Obara, Katsutoshi; Sakaida, Isao; Shibuya, Akitaka; Seike, Masataka; Nagoshi, Sumiko; Segawa, Makoto; Tsubouchi, Hirohito; Moriwaki, Hisataka; Kato, Akinobu; Hashimoto, Etsuko; Michitaka, Kojiro; Murawaki, Toshikazu; Sugano, Kentaro; Watanabe, Mamoru; Shimosegawa, Tooru
errShare
errSave
Reduction of endotoxin attenuates liver fibrosis through suppression of hepatic stellate cell activation and remission of intestinal permeability in a rat non-alcoholic steatohepatitis model
err2014-11-24
err66
errOAAI
errDouhara, Akitoshi; Moriya, Kei; Yoshiji, Hitoshi; Noguchi, Ryuichi; Namisaki, Tadashi; Kitade, Mitsuteru; Kaji, Kosuke; Aihara, Yosuke; Nishimura, Norihisa; Takeda, Kosuke; Okura, Yasushi; Kawaratani, Hideto; Fukui, Hiroshi
errShare
errSave
Combination of sorafenib and angiotensin-II receptor blocker attenuates preneoplastic lesion development in a non-diabetic rat model of steatohepatitis
err2013-11-07
err20
PREAI
errYoshiji, Hitoshi; Noguchi, Ryuichi; Namisaki, Tadashi; Moriya, Kei; Kitade, Mitsuteru; Aihara, Yosuke; Douhara, Akitoshi; Kawaratani, Hideto; Nishimura, Norihisa; Fukui, Hiroshi
errShare
errSave
Branched-chain amino acids suppress the cumulative recurrence of hepatocellular carcinoma under conditions of insulin-resistance
err2013-05-27
err25
errOAAI
errYoshiji, Hitoshi; Noguchi, Ryuichi; Namisaki, Tadashi; Moriya, Kei; Kitade, Mitsuteru; Aihara, Yosuke; Douhara, Akitoshi; Yamao, Junichi; Fujimoto, Masao; Toyohara, Masahisa; Mitoro, Akira; Sawai, Masayoshi; Yoshida, Motoyuki; Morioka, Chie; Uejima, Masakazu; Uemura, Masahito; Fukui, Hiroshi
errShare
errSave
Direct renin inhibitor attenuates rat hepatocarcinogenesis via anti-angiogenic activity
err2013-04-01
err0
PREAI
errAihara, Yosuke; Yoshiji, Hitoshi; Noguchi, Ryuichi; Kaji, Kosuke; Namisaki, Tadashi; Moriya, Kei; Kitade, Mitsuteru; Fukui, Hiroshi
errShare
errSave
Response-guided anti-angiogenic therapy for hepatocellular carcinoma recurrence with clinically available safety agent.
err2013-04-01
err0
PREAI
errYoshiji, Hitoshi; Noguchi, Ryuichi; Kaji, Kosuke; Aihara, Yosuke; Namisaki, Tadashi; Moriya, Kei; Douhara, Akitoshi; Kitade, Mitsuteru; Fukui, Hiroshi
errShare
errSave
Cross talk between toll-like receptor-4 signaling and angiotensin-II in liver fibrosis development in the rat model of non-alcoholic steatohepatitis
err2013-03-25
err47
PREAI
errShirai, Yusaku; Yoshiji, Hitoshi; Noguchi, Ryuichi; Kaji, Kosuke; Aihara, Yosuke; Douhara, Akitoshi; Moriya, Kei; Namisaki, Tadashi; Kawaratani, Hideto; Fukui, Hiroshi
errShare
errSave
Dipeptidyl peptidase-4 inhibitor attenuates hepatic fibrosis via suppression of activated hepatic stellate cell in rats
err2013-03-12
err103
PREAI
errKaji, Kosuke; Yoshiji, Hitoshi; Ikenaka, Yasuhide; Noguchi, Ryuichi; Aihara, Yosuke; Douhara, Akitoshi; Moriya, Kei; Kawaratani, Hideto; Shirai, Yusaku; Yoshii, Junichi; Yanase, Koji; Kitade, Mitsuteru; Namisaki, Tadashi; Fukui, Hiroshi
errShare
errSave
Direct renin inhibitor, aliskiren, attenuates the progression of non-alcoholic steatohepatitis in the rat model
err2013-02-28
err22
errOAAI
errAihara, Yosuke; Yoshiji, Hitoshi; Noguchi, Ryuichi; Kaji, Kosuke; Namisaki, Tadashi; Shirai, Yusaku; Douhara, Akitoshi; Moriya, Kei; Kawaratani, Hideto; Fukui, Hiroshi
errShare
errSave
The Effect of Inflammatory Cytokines in Alcoholic Liver Disease
err2013-01-01
err202
errOAAI
errKawaratani, Hideto; Tsujimoto, Tatsuhiro; Douhara, Akitoshi; Takaya, Hiroaki; Moriya, Kei; Namisaki, Tadashi; Noguchi, Ryuichi; Yoshiji, Hitoshi; Fujimoto, Masao; Fukui, Hiroshi
errShare
errSave